Amino Acid-Based Boron Carriers in Boron Neutron Capture Therapy (BNCT). [PDF]
Interest in the design of boronated amino acids has emerged, partly due to the utilization of boronophenylalanine (BPA), one of the two agents employed in clinical Boron Neutron Capture Therapy (BNCT). The boronated amino acids synthesized thus far for BNCT investigations can be classified into two categories based on the source of boron: boronic acids
Järvinen J +3 more
europepmc +5 more sources
Advances in Boron Neutron Capture Therapy (BNCT) for Recurrent Intracranial Meningioma. [PDF]
Meningiomas are the most frequently diagnosed primary intracranial tumors in adults. Surgical resection is preferred if the meningioma is accessible; for those that are not suitable for surgical resection, radiotherapy should be considered to improve local tumor control.
Lan TL +11 more
europepmc +4 more sources
Optimizing Boron Neutron Capture Therapy (BNCT) to Treat Cancer: An Updated Review on the Latest Developments on Boron Compounds and Strategies. [PDF]
Optimizing Boron Neutron Capture Therapy (BNCT) to Treat Cancer: An Updated Review on the Latest Developments on Boron Compounds and StrategiesAndrea Monti Hughes 1 2, Naonori Hu 3 4Affiliations1Radiation Pathology Division, Department Radiobiology ...
Monti Hughes A, Hu N.
europepmc +4 more sources
Chordoma Treatment with Boron Neutron Capture Therapy (BNCT): Experimental Insights
Boron Neutron Capture Therapy (BNCT) is a particle beam therapy that enables the precise targeting of tumors at the cellular level [...]
Yoshiki Fujikawa +9 more
doaj +4 more sources
Quantification of <sup>10</sup>B and <sup>11</sup>B in Biological Samples in Translational Science and Clinical Applications for Boron Neutron Capture Therapy (BNCT). [PDF]
ABSTRACT Boron neutron capture therapy (BNCT) is a targeted radiotherapy that exploits the selective accumulation of the 10B isotope within tumors, followed by irradiation with low‐energy neutrons to induce high linear energy transfer particles with short path lengths, resulting in localized tumor cell destruction while sparing surrounding healthy ...
Selg C, Sauerwein WAG, Hey-Hawkins E.
europepmc +2 more sources
Safety, efficacy, pharmacokinetics, and mechanisms of novel <sup>10</sup>B-boronophenylalanine combined with a radio-frequency quadrupole accelerator in boron neutron capture therapy: A preclinical study in head and neck squamous cell carcinoma. [PDF]
This study demonstrates that the novel 10B‐BPA‐based BNCT system, combined with an RFQ accelerator, effectively targets head and neck squamous cell carcinoma. It induces tumor regression safely and efficiently by triggering DNA damage and activating the ROS/HIF‐1α/NF‐κB pathway, leading to caspase‐3‐mediated apoptosis.
Zhang Z +13 more
europepmc +2 more sources
Transporter-Associated Therapeutic Efficacy of an SMVT-Targeted Boron Carrier in Boron Neutron Capture Therapy. [PDF]
The transporter‐associated BNCT strategy using BBCIP with or without BPA according to tumor transporter characteristics. BPA showed greater efficacy in LAT1‐dominant F98 glioma, whereas BBCIP was more effective in SMVT‐high CRL1666 tumors, suggesting the potential utility of transporter‐based boron carrier selection in BNCT.
Eza K +15 more
europepmc +2 more sources
Exploring the Biological and Physical Basis of Boron Neutron Capture Therapy (BNCT) as a Promising Treatment Frontier in Breast Cancer. [PDF]
Seneviratne D +6 more
europepmc +2 more sources
In Vivo Application of Carboranes for Boron Neutron Capture Therapy (BNCT): Structure, Formulation and Analytical Methods for Detection. [PDF]
Marforio TD, Carboni A, Calvaresi M.
europepmc +2 more sources

